Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889
These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.Cell processing segment to witness the highest growth during the forecast period :Based on process, the cell therapy technologies market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest market share in 2018 and is projected to witness the highest CAGR during the forecasted period.Browse and in-depth TOC on “Cell Therapy Technologies Market”75 - Tables30 - Figures116 - PagesTo Get Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978Key players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).Thermo Fisher was the largest player in the Cell Therapy Technologies Market in 2017. In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions. Merck holds the second position in the cell therapy technologies market. The company focuses on collaborations, agreements, and acquisitions to enhance its market position.North America to dominate the cell therapy technologies market during the forecast period :The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018 owing to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=213334978
Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.According to the new market research report "Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets™, The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
Glycobiology Market DynamicsDrivers1. Increasing funding for Proteomics & glycomics research and growingR&D expenditure2. Growth of the proteomics market3. Technological advancements in glycomics instrumentationRestraints1. High degree of consolidation acts as an entry barrier for new entrants2. Stringent regulatory frameworks and time-consuming approval processesOpportunities1. Increased use of personalized medicine2. Biomarkers identification3. Developing countries and emerging marketsChallenges1. High cost of tools and instruments and their maintenanceGet Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525Key Players and Strategies Adopted by Them:The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).Oncology :Glycomics plays a crucial role in analyzing the molecular mechanism of various types of cancers. Glycomics also plays an important role in identifying new biomarkers for cancers. Biomarkers are used as key diagnostic targets for various types of cancers. They can also be used for devising novel and personalized therapies for cancer patients. Owing to its ability to differentiate between protein sub-types based on the molecular structure of their glycan patterns, glycomics has emerged as an important research tool for the discovery and validation of protein-based cancer biomarkers.
Glycobiology is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525According to the new market research report "Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets™, The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.The following are the major objectives of the study :1. To define, describe, and forecast the global glycobiology market on the basis of product, application, end user, and region2. To provide detailed information regarding the major factors influencing the growth of the glycobiology market (drivers, restraints, opportunities, and industry-specific challenges)3. To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall Glycobiology market4. To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders5. To forecast the Glycobiology market size of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World6. To strategically profile the key players and comprehensively analyze their market shares and core competencies27. To track and analyze the competitive developments such as new product launches, agreements, collaborations, acquisitions, expansion and agreements in the glycomics marketGet Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525Oncology :Glycomics plays a crucial role in analyzing the molecular mechanism of various types of cancers. Glycomics also plays an important role in identifying new biomarkers for cancers. Biomarkers are used as key diagnostic targets for various types of cancers. They can also be used for devising novel and personalized therapies for cancer patients. Owing to its ability to differentiate between protein sub-types based on the molecular structure of their glycan patterns, glycomics has emerged as an important research tool for the discovery and validation of protein-based cancer biomarkers.Key Players and Strategies Adopted by Them:The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).
According to the new market research report "Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets™, The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525Glycobiology is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.The following are the major objectives of the study :1. To define, describe, and forecast the global glycobiology market on the basis of product, application, end user, and region2. To provide detailed information regarding the major factors influencing the growth of the glycobiology market (drivers, restraints, opportunities, and industry-specific challenges)3. To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall Glycobiology market4. To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders5. To forecast the Glycobiology market size of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World6. To strategically profile the key players and comprehensively analyze their market shares and core competencies27. To track and analyze the competitive developments such as new product launches, agreements, collaborations, acquisitions, expansion and agreements in the glycomics marketGet Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525Key Players and Strategies Adopted by Them:The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).Oncology :Glycomics plays a crucial role in analyzing the molecular mechanism of various types of cancers. Glycomics also plays an important role in identifying new biomarkers for cancers. Biomarkers are used as key diagnostic targets for various types of cancers. They can also be used for devising novel and personalized therapies for cancer patients. Owing to its ability to differentiate between protein sub-types based on the molecular structure of their glycan patterns, glycomics has emerged as an important research tool for the discovery and validation of protein-based cancer biomarkers.
Factors such as the shift from parenteral to enteral nutrition along with the increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the Oncology Nutrition Market. Furthermore, the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of excipients|What the Market Looks Like?Predicted to grow at a CAGR of 8.7% during the forecast period, the Oncology Nutrition Market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023.Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancer’s cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967
Objectives of the Study:• To define, describe, segment, and forecast the Oncology Nutrition Market for different types of cancer• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, and industry-specific opportunities)• To forecast the size of the Oncology Nutrition Market, in four main regions —North America (along with countries), Europe (along with countries), Asia Pacific, and the Rest of the World
• To identify and profile key players in the global Oncology Nutrition Market and comprehensively analyze their core competencies and market sharesGet 10% Customization on Research Report:https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=166703967Geographical growth scenario of Oncology Nutrition Market:The Oncology Nutrition Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.Leading market players and strategies adopted:The major players in the Oncology Nutrition Market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/oncology-nutrition.asp
